iRhythm Technologies, Inc.

39 Days Left

Class Action Period:
January 11, 2022 - May 30, 2023

Lead Plaintiff Deadline:
April 08, 2024

Case Form

Find Out if You Potentially Qualify for a Financial Reward by filling out the form.












The submission of this form does not create an attorney-client relationship.

Allegations

According to the lawsuit, defendants falsely represented to investors that one of iRhythm’s main products, the Zio AT monitor, was a real-time heart monitor intended for high-risk patients. Specifically, defendants repeatedly touted the potential growth for the Zio AT as an innovative product that had only just begun to penetrate the market for real-time monitoring, which investors looked upon favorably given the premium selling price associated with devices approved for high-risk patients. As a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices throughout the class period.

Eligibility

In order to be included in the lawsuit, you must have incurred a loss on shares of iRhythm Technologies purchased during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in iRhythm Technologies during the relevant time frame, you have until April 08, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.